ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Prostaglandins are produced via a different pathway in the brain than elsewhere in the body, scientists report (Science, DOI: 10.1126/science.1209200). These inflammation mediators are made by cyclooxygenase (COX) enzymes using arachidonic acid as a precursor. Researchers have assumed that phospholipase A2 enzymes are the primary source of that arachidonic acid, but Daniel K. Nomura of the University of California, Berkeley; Benjamin F. Cravatt of Scripps Research Institute; and coworkers show that in the brain the enzyme monoacylglycerol lipase (MAGL) hydrolyzes the endocannabinoid 2-arachidonoylglycerol to produce the arachidonic acid used to make prostaglandins. Mice treated with a MAGL inhibitor produced less arachidonic acid and prostaglandins in response to the proinflammatory agent lipopolysaccharide. MAGL could be a good target for anti-inflammatory medications without the gastrointestinal effects of drugs that target COX enzymes, the researchers suggest. Lawrence J. Marnett, a prostaglandin expert at Vanderbilt University, says, “This work will rewrite textbooks on the biochemistry of prostaglandin generation in the brain.”
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X